Page last updated: 2024-08-21

pyrazines and Leukemia, Lymphoid

pyrazines has been researched along with Leukemia, Lymphoid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ball, G; Beran, M; Cortes-Franco, JE; Divoky, V; Gatto, S; Kantarjian, HM; Keating, MJ; Milella, M; Onida, F; Pham, L; Ricci, C; Scappini, B; Verstovsek, S1
Armstrong, JS; Boelsterli, U; Chua, YL; Moore, PK; Whiteman, M; Zhang, D1

Other Studies

2 other study(ies) available for pyrazines and Leukemia, Lymphoid

ArticleYear
The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.
    Haematologica, 2003, Volume: 88, Issue:8

    Topics: Apoptosis; Benzamides; Boronic Acids; Bortezomib; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Drug Combinations; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Genes, abl; Humans; I-kappa B Proteins; Imatinib Mesylate; Leukemia, Lymphoid; Leukemia, Myeloid; Multienzyme Complexes; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Piperazines; Proteasome Endopeptidase Complex; Pyrazines; Pyrimidines

2003
Oltipraz-induced phase 2 enzyme response conserved in cells lacking mitochondrial DNA.
    Biochemical and biophysical research communications, 2005, Nov-11, Volume: 337, Issue:1

    Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Survival; DNA, Mitochondrial; Glutathione; Glutathione Transferase; Humans; Leukemia, Lymphoid; Membrane Potentials; Mitochondria; Oxidative Stress; Pyrazines; Reactive Oxygen Species; Thiones; Thiophenes

2005